or Sm/U1RNP) have been targeted by the autoantibody response.
Experiments with mice expressing transgenes encoding self-reactive antibodies have demonstrated that B cell development involves a process of tolerance that deletes or functionally inactivates autoreactive cells, including some specificities characteristic of SLE (reviewed by Goodnow et al., 1995; Chen et al., 1995) . However, it is important to note that provision of a powerful CD4 T cell driving force is sufficient for lupus-like IgG autoantibody production and disease to develop in normal animals. This is observed, for example, in models of chronic graft-versus-host disease in which the transferred T cells are alloreactive, and these studies indicate that potentially pathologic B cells are part of the peripheral repertoire or rapidly develop during this T celldriven process. Thus, defects in central B cell tolerance do not appear to be necessary to allow for lupus-like autoantibody production. Furthermore, the ability of normal animals to generate autoantibody responses that spread to multiple determinants on a particular nuclear complex after immunization with one peptide or component of this complex also supports this conclusion (Bockenstedt et al., 1995; Topfer et al., 1995; James et al., 1995) .
CD4 T Cell Dependence of Autoantibody Production
The association of SLE with particular class II major histocompatibility complex (MHC) alleles and the affinity maturation of IgG autoantibody production in this disease strongly suggest that CD4 T cells are important in the pathogenesis of disease. Furthermore, in all of the ies can ameliorate IgG autoantibody production and disease. Additional studies indicate that blocking T cell activation or T cell-B cell interactions will also prevent genetic studies have suggested a major pathogenic role autoantibody production and disease (Finck et al., 1994 ; for autoantibodies to the endogenous retroviral glyco- Mohan et al., 1995) . The specificities of the autoreactive protein (gp70) and gp70-anti-gp70 immune complexes T cells, however, have not been well characterized, and (Izui et al., 1981) .
the nature of T cell help in SLE may indeed differ from conventional responses. In the anti-DNA response, it seems unlikely that T cells directed to DNA determinants B Cell Tolerance and Activation in Lupus are operative. Studies in murine lupus have shown that Evidence strongly supports the conclusions that pathoa non-DNA nucleosomal antigen stimulates some autogenic IgG autoantibody production in SLE is selective reactive T cells that drive anti-DNA antibody-producing for only certain self-antigens and that autoreactive B B cells (Mohan et al., 1993) . Thus, a DNA-specific B cell cells are driven by self-antigens. In SLE and lupus mice, could bind and internalize nucleosomes, with subsestudies have repeatedly shown that a subset of antiquent class II MHC presentation of histone or other DNA antibody-producing B cells are clonally expanded chromosomal peptides to T cells. In other studies, immuand that their immunoglobulin genes are modified by noglobulin peptides derived from an IgG anti-DNA autosomatic mutation (reviewed by Radic et al., 1993) . This antibody were shown to stimulate T cells from (NZB ϫ process mimics a normal T cell-dependent response NZW)F1 mice and enhance IgG anti-DNA antibody proto foreign antigen, involving common mechanisms of duction (Singh et al., 1995) . somatic mutation, affinity maturation, and IgM to IgG
In studies relevant to organ-specific autoimmune disclass switching. Studies have shown that anti-DNA antieases such as multiple sclerosis and type 1 diabetes bodies in lupus preferentially utilize certain V H and V L mellitus, the evidence indicates that autoimmune and genes. Analysis of their complementarity-determining potentially disease-causing T cells are present in the normal peripheral T cell repertoire. Thus, these T cells regions (CDRs), especially CDR3, have shown an increased number of arginine residues that enhance the were not deleted during normal development in the thymus, and their inactivity appears to be maintained by binding of antibody to DNA and suggest selection by DNA itself (Radic et al., 1993) . That self-antigen is inprotective mechanisms of peripheral tolerance-functional inactivation, immunoregulation, and immunologivolved in anti-nuclear antibody production in lupus is further supported by studies showing that multiple epical ignorance. The same scenario may exist for lupusrelevant T cells despite the ubiquitous nature of the topes on the same autoantigen particle (e.g., chromatin target autoantigens. Studies in lupus mice, for example, model and one phenotype is being considered, the gehave suggested that high affinity responses to self-antinetic basis of lupus-like disease is remarkably complex, gens are tolerized normally in the thymus (Herron et al., involving contributions from multiple genes in addition 1993). Other work has indicated that dominant determito class II MHC (Drake et al., 1995; Morel et al., 1994 ; nants of a self-antigen that are processed and presented Kono et al., 1994) . Furthermore, it seems likely that difefficiently in the thymus will be effective tolerogens, but ferent genetic contributions are operative in different T cells directed to cryptic self-determinants may escape animal models (and therefore in different patients), even tolerance induction and be part of the normal peripheral when the same phenotype is being followed. Some traits T cell repertoire (reviewed by Sercarz et al., 1993) . Thereappear to be determined in a threshold manner (Morel fore, abnormal presentation of such cryptic determiet al., 1994; Drake et al., 1995) . Thus, the particular nants in the periphery or a defect in peripheral T cell combination of genes may be less important than just tolerance in SLE could allow activation of autoimmune the accumulation of an adequate number of predispos-T cells. Immunization of normal mice with cryptic peping genes. An additional complexity relates to the fact tides of a self-nuclear antigen has been shown to result that contributions are unlikely to represent genetic muin lupus-like autoantibody production (Bockenstedt et tations rather than polymorphic alleles with subtle funcal., 1995).
tional differences. Related to this issue, in some analyPatterns of cytokine production by T cells appear to be ses of genes from lupus-prone strains, genes from the critically important in diseases such as multiple sclerosis normal strain can be shown to have enhancing effects and type 1 diabetes. These diseases appear to be deon disease expression (Drake et al., 1995) . pendent on Th1-type responses, and deviation from this In addition to class II MHC genes, there is evidence pattern may lead to protection from disease expression.
that genetically determined complement deficiencies In SLE, Th2-type responses may be important in disease also contribute to disease susceptibility in a subset of development, as demonstrated in the chronic graft-ver-SLE patients. The mechanism for this influence is unsus-host model of disease. However, in spontaneous known. Some investigators have postulated defects in murine models, the IgG isotypes most important for the clearance of infectious particles or immune compathogenicity (IgG2a, IgG2b, and IgG3) suggest the adplexes, leading to enhanced autoantibody production. ditional influence of Th1-type cytokines and the imporAlternatively, complement gene defects may exemplify tance of interferon-␥. Although there is a wealth of data genetic influences that operate distal to autoantibody regarding defects in cytokine production and immunoproduction, and similar genetic contributions appear to regulatory T cells in SLE, it is not clear at this time be present in murine lupus nephritis. For example, these whether any are primary to the pathologic process.
genetic contributions may allow enhanced deposition or formation of immune complexes in the kidney or posEnvironmental Triggers and Influences sibly affect the inflammatory response or end-organ reEnvironmental influences on the expression of disease sponse to complexes. manifestations are clearly seen in SLE. These include the A possible step forward in understanding genetic conexacerbation of skin rash (or even systemic symptoms) tributions in lupus relates to the identification of lpr and after sun exposure, exacerbations of disease after viral gld as mutations in Fas and Fas ligands, respectively, or bacterial infections, and changes in disease activity which are involved in programmed cell death (apoptosis) after administration of exogenous hormones. It is also (reviewed by Cohen and Eisenberg, 1991;  van Houten clear that chronic treatment of patients with certain and Budd, 1994). Homozygosity for these mutations redrugs (such as procainamide or hydralazine) can induce sults in the acceleration of lupus-like autoimmunity as the production of anti-nuclear antibodies and a lupuswell as a massive accumulation of CD4 Ϫ CD8 Ϫ (double like disease (reviewed by Kotzin and O'Dell, 1995) and negative) T cells. Full expression of lupus-like disease that intraperitoneal injection with pristane (2,6,10,14-in MRL-lpr/lpr mice is dependent on contributions from tetramethylpentadecane) can induce a lupus-like disother non-MHC genes. Although the mechanism by ease in normal mice (Satoh et al., 1995) . Despite this which mutations in Fas lead to accelerated autoimmuinformation, there is no clear evidence that an environnity is unknown, the strongest hypothesis is that selfmental trigger is involved in the initiation of human SLE.
reactive T and B cells arise when they fail to undergo The fact that approximately 75% of monozygotic twins apoptosis normally. Studies have shown that both T are discordant for disease expression has also been cells and B cells must carry the lpr mutation for maximal used as evidence to support the existence of an environautoantibody production to occur. Fas may not be immental stimulus. However, mouse strains can also be portant in intrathymic tolerance during T cell developcreated such that 25% reproducibly develop disease or ment, and studies support the contention that peripheral produce particular autoantibodies, and careful examina-T cell tolerance mechanisms are primarily affected by tion of positive mice has excluded environmental effects the lpr mutation (Herron et al., 1993 ; Singer and Abbas, as the major factor in variable expression (Eisenberg et 1994) . Studies suggest that central B cell tolerance also al., 1987; Drake et al., 1995) . In these mice, the probabilmay be relatively independent of Fas, and surface exity of disease appears to be totally genetically deterpression of Fas on B cells may be most important in mined, and unknown stochastic (random) events deterpreventing inappropriate CD4 T cell-dependent expanmine which will develop disease. Overall, the importance sion of autoreactive B cells in the periphery (Goodnow of environmental triggers in human SLE remains unclear. et al., 1995; Rathmell and Goodnow, 1994; Rathmell et al., 1995; Rothstein et al., 1995 disease.
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